Related Experiment Video
Updated: Jan 22, 2026

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
Published on: May 21, 2017
Coronary artery disease in patients undergoing transcatheter aortic valve replacement: Current evidence and future
Bahaa El Deen Wehbeh1, Moied Al Sakan2, Jamil Francis2
1Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Insights
Managing coronary artery disease (CAD) in patients undergoing transcatheter aortic valve replacement (TAVR) is complex. Revascularization may benefit those with complex CAD, but routine intervention for stable CAD offers limited advantages.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiovascular Surgery
Background:
- Coronary artery disease (CAD) and aortic stenosis (AS) frequently coexist, posing management challenges.
- Optimal treatment strategies for CAD in patients undergoing transcatheter aortic valve replacement (TAVR) lack clear definition due to limited evidence.
Purpose of the Study:
- To review the epidemiology and pathophysiology linking CAD and AS.
- To summarize diagnostic approaches for CAD in the TAVR population.
- To evaluate revascularization strategies, focusing on percutaneous coronary intervention (PCI) timing relative to TAVR.
Main Methods:
- Comprehensive literature review integrating current evidence.
- Analysis of diagnostic algorithms for CAD in TAVR candidates.
- Evaluation of revascularization strategies, including PCI timing.
Main Results:
- Routine PCI for stable CAD in TAVR candidates shows limited benefit.
- Revascularization for complex CAD or high anatomical burden may improve outcomes.
- Characterization of post-TAVR coronary events, their mechanisms, and prognostic impact.
Conclusions:
- Personalized revascularization strategies are crucial for CAD patients undergoing TAVR.
- Further research is needed to optimize outcomes in this high-risk cohort.
- Emerging strategies aim to improve both ischemic and procedural results post-TAVR.
Abstract:
Coronary artery disease (CAD) coexists frequently with aortic stenosis (AS), and the optimal management of CAD in patients undergoing transcatheter aortic valve replacement (TAVR) remains incompletely defined due to limited and heterogeneous evidence. This review aims to integrate the current evidence on the epidemiology and shared pathophysiology of CAD and AS, summarize the diagnostic algorithms for CAD in the TAVR population, and evaluates revascularization strategies with a focus on the timing of percutaneous coronary intervention relative to valve replacement. Current evidence suggests that while routine PCI in TAVR candidates for stable CAD may offer limited benefit, revascularization in patients with complex CAD or high anatomical burden may improve outcomes. This review further characterizes the incidence, proposed mechanisms, and prognostic significance of post-TAVR coronary events and outlines emerging strategies to optimize ischemic and procedural outcomes in this high-risk cohort.
More Related Videos
14:14Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
05:31Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease V: Interprofessional Care
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease IV: Preventive Measures
The Evidence for Evolution